vs

Side-by-side financial comparison of FIRST INTERSTATE BANCSYSTEM INC (FIBK) and NEOGENOMICS INC (NEO). Click either name above to swap in a different company.

FIRST INTERSTATE BANCSYSTEM INC is the larger business by last-quarter revenue ($313.0M vs $186.7M, roughly 1.7× NEOGENOMICS INC). FIRST INTERSTATE BANCSYSTEM INC runs the higher net margin — 34.8% vs -57.9%, a 92.6% gap on every dollar of revenue. On growth, FIRST INTERSTATE BANCSYSTEM INC posted the faster year-over-year revenue change (19.8% vs 11.1%). Over the past eight quarters, FIRST INTERSTATE BANCSYSTEM INC's revenue compounded faster (13.7% CAGR vs 6.5%).

First Interstate BancSystem, Inc. is a financial holding company headquartered in Billings, Montana. It is the parent company of First Interstate Bank, a community bank with locations throughout 14 states within the Western and Midwestern United States. It is the largest bank based in Montana, as measured by total assets.

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

FIBK vs NEO — Head-to-Head

Bigger by revenue
FIBK
FIBK
1.7× larger
FIBK
$313.0M
$186.7M
NEO
Growing faster (revenue YoY)
FIBK
FIBK
+8.7% gap
FIBK
19.8%
11.1%
NEO
Higher net margin
FIBK
FIBK
92.6% more per $
FIBK
34.8%
-57.9%
NEO
Faster 2-yr revenue CAGR
FIBK
FIBK
Annualised
FIBK
13.7%
6.5%
NEO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
FIBK
FIBK
NEO
NEO
Revenue
$313.0M
$186.7M
Net Profit
$108.8M
$-108.0M
Gross Margin
43.3%
Operating Margin
44.5%
46.9%
Net Margin
34.8%
-57.9%
Revenue YoY
19.8%
11.1%
Net Profit YoY
108.8%
42.0%
EPS (diluted)
$1.07
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FIBK
FIBK
NEO
NEO
Q1 26
$186.7M
Q4 25
$313.0M
$190.2M
Q3 25
$250.5M
$187.8M
Q2 25
$248.3M
$181.3M
Q1 25
$247.0M
$168.0M
Q4 24
$261.3M
$172.0M
Q3 24
$251.9M
$167.8M
Q2 24
$244.3M
$164.5M
Net Profit
FIBK
FIBK
NEO
NEO
Q1 26
$-108.0M
Q4 25
$108.8M
Q3 25
$71.4M
$-27.1M
Q2 25
$71.7M
$-45.1M
Q1 25
$50.2M
$-25.9M
Q4 24
$52.1M
Q3 24
$55.5M
$-17.7M
Q2 24
$60.0M
$-18.6M
Gross Margin
FIBK
FIBK
NEO
NEO
Q1 26
43.3%
Q4 25
43.8%
Q3 25
42.8%
Q2 25
42.6%
Q1 25
43.6%
Q4 24
44.9%
Q3 24
44.6%
Q2 24
44.1%
Operating Margin
FIBK
FIBK
NEO
NEO
Q1 26
46.9%
Q4 25
44.5%
-7.1%
Q3 25
37.0%
-14.4%
Q2 25
37.7%
-26.3%
Q1 25
26.9%
-16.6%
Q4 24
25.5%
-10.7%
Q3 24
28.9%
-12.6%
Q2 24
32.1%
-13.3%
Net Margin
FIBK
FIBK
NEO
NEO
Q1 26
-57.9%
Q4 25
34.8%
Q3 25
28.5%
-14.4%
Q2 25
28.9%
-24.9%
Q1 25
20.3%
-15.4%
Q4 24
19.9%
Q3 24
22.0%
-10.5%
Q2 24
24.6%
-11.3%
EPS (diluted)
FIBK
FIBK
NEO
NEO
Q1 26
$-0.13
Q4 25
$1.07
Q3 25
$0.69
Q2 25
$0.69
Q1 25
$0.49
Q4 24
$0.50
Q3 24
$0.54
Q2 24
$0.58

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FIBK
FIBK
NEO
NEO
Cash + ST InvestmentsLiquidity on hand
$146.1M
Total DebtLower is stronger
$146.3M
Stockholders' EquityBook value
$3.4B
$828.8M
Total Assets
$26.6B
$1.3B
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FIBK
FIBK
NEO
NEO
Q1 26
$146.1M
Q4 25
$159.6M
Q3 25
$164.1M
Q2 25
$154.7M
Q1 25
$346.2M
Q4 24
$367.0M
Q3 24
$362.0M
Q2 24
$355.1M
Total Debt
FIBK
FIBK
NEO
NEO
Q1 26
Q4 25
$146.3M
$341.9M
Q3 25
$146.2M
Q2 25
$252.0M
Q1 25
Q4 24
$132.2M
$541.1M
Q3 24
$137.3M
Q2 24
$383.4M
Stockholders' Equity
FIBK
FIBK
NEO
NEO
Q1 26
$828.8M
Q4 25
$3.4B
$836.6M
Q3 25
$3.4B
$838.3M
Q2 25
$3.4B
$854.0M
Q1 25
$3.4B
$888.3M
Q4 24
$3.3B
$902.3M
Q3 24
$3.4B
$908.2M
Q2 24
$3.2B
$915.9M
Total Assets
FIBK
FIBK
NEO
NEO
Q1 26
$1.3B
Q4 25
$26.6B
$1.4B
Q3 25
$27.3B
$1.4B
Q2 25
$27.6B
$1.4B
Q1 25
$28.3B
$1.6B
Q4 24
$29.1B
$1.6B
Q3 24
$29.6B
$1.6B
Q2 24
$30.3B
$1.6B
Debt / Equity
FIBK
FIBK
NEO
NEO
Q1 26
Q4 25
0.04×
0.41×
Q3 25
0.04×
Q2 25
0.07×
Q1 25
Q4 24
0.04×
0.60×
Q3 24
0.04×
Q2 24
0.12×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FIBK
FIBK
NEO
NEO
Operating Cash FlowLast quarter
$305.6M
$-8.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
2.81×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FIBK
FIBK
NEO
NEO
Q1 26
$-8.1M
Q4 25
$305.6M
$1.3M
Q3 25
$91.7M
$8.9M
Q2 25
$68.1M
$20.3M
Q1 25
$78.5M
$-25.3M
Q4 24
$355.0M
$9.8M
Q3 24
$89.9M
$9.2M
Q2 24
$82.3M
$13.9M
Free Cash Flow
FIBK
FIBK
NEO
NEO
Q1 26
Q4 25
$-6.5M
Q3 25
$570.0K
Q2 25
$14.0M
Q1 25
$-29.8M
Q4 24
$-1.8M
Q3 24
$-1.6M
Q2 24
$814.0K
FCF Margin
FIBK
FIBK
NEO
NEO
Q1 26
Q4 25
-3.4%
Q3 25
0.3%
Q2 25
7.7%
Q1 25
-17.8%
Q4 24
-1.0%
Q3 24
-0.9%
Q2 24
0.5%
Capex Intensity
FIBK
FIBK
NEO
NEO
Q1 26
Q4 25
4.1%
Q3 25
4.4%
Q2 25
3.5%
Q1 25
2.7%
Q4 24
6.7%
Q3 24
6.4%
Q2 24
8.0%
Cash Conversion
FIBK
FIBK
NEO
NEO
Q1 26
Q4 25
2.81×
Q3 25
1.28×
Q2 25
0.95×
Q1 25
1.56×
Q4 24
6.81×
Q3 24
1.62×
Q2 24
1.37×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons